Closely monitor main function index during infusion. Monitor leukocyte counts frequently. Decrease dosage in case of severe neutropenia (<500 cells/mm
3 & duration of ≥7 days) & severe peripheral neurotoxicity. Discontinue therapy if severe hypersensitivity reactions eg, decrease BP by >20 mmHg, bronchospasm or eruption/erythema; & cutaneous reactions eg, localized erythema of extremities, edema & desquamation occur. Childn.